Cilostazol and peripheral artery disease-specific health status in ambulatory patients with symptomatic PAD

Mohammed, M; Gosch, K; Safley, D; Jelani, QU; Aronow, HD; Mena, C; Shishehbor, MH; Spertus, JA; Abbott, JD; Smolderen, KG

Smolderen, KG (corresponding author), Yale Univ, Yale New Haven Hosp, Sect Cardiovasc Med, POB 208017, New Haven, CT 06520 USA.

INTERNATIONAL JOURNAL OF CARDIOLOGY, 2020; 316 (): 222

Abstract

Background: Improvement of symptoms and functional status is one of the main peripheral artery disease (PAD) treatment goals but pharmacological optio......

Full Text Link